Treace Medical Concepts, Inc.
Treace Medical Concepts, Inc. (TMCI) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
tmci · pe ratio · data through Dec 31, 2025
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for Treace Medical Concepts, Inc. (TMCI) measures how much investors pay for each dollar of the company's trailing earnings. TMCI's current PE ratio of N/A is calculated by dividing its stock price of $3.53 by its TTM earnings per share of -$0.95.
Source: FMP · /ratios-ttm · /analyst-estimates · 2025-12-31
PE Ratio History
2019 – 2025 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
PE Ratio vs Peers
Medical - Devices · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Treace Medical Concepts, Inc.You TMCI | $229M | N/A | — | -$0.95 |
 Bioventus Inc. BVS | $606M | 21.81x | — | $0.34 |
 CeriBell, Inc. CBLL | $688M | N/A | — | -$1.46 |
 Enhabit, Inc. EHAB | $707M | N/A | — | -$0.09 |
 Evolus, Inc. EOLS | $440M | N/A | — | -$0.80 |
 OrthoPediatrics Corp. KIDS | $468M | N/A | — | -$1.69 |
 Standard BioTools Inc. LAB | $314M | N/A | — | -$0.20 |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2025-12-31Latest FY2025 | — | $-0.93 | — | |
2024-12-31 FY2024 | — | $-0.90 | — | |
2023-12-31 FY2023 | — | $-0.81 | — | |
2022-12-31 FY2022 | — | $-0.77 | — | |
2021-12-31 FY2021 | — | $-0.38 | — | |
2020-12-31 FY2020 | — | $-0.07 | — | |
2019-12-31 FY2019 | — | $-0.08 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Treace Medical Concepts, Inc. (TMCI) measures how much investors pay for each dollar of the company's trailing earnings. TMCI's current PE ratio of N/A is calculated by dividing its stock price of $3.53 by its TTM earnings per share of -$0.95.
Frequently asked questions
TMCI pe ratio · 6 questionsTMCI's current PE ratio is N/A as of 2026-06-08, based on a stock price of $3.53 and TTM EPS of -$0.95. Data sourced from Financial Modeling Prep via TMCI's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Treace Medical Concepts, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-08